Nitric oxide (NO) is a free radical that is important in retinal
signal transduction and cyclic guanosine monophosphate (cGMP) is a
critical downstream messenger of NO. The NO/cGMP signaling pathway has
been shown to modulate neurotransmitter release and gap junction coupling
in horizontal cells and amacrine cells, and increase the gain of the light
response in photoreceptors. However, many of the mechanisms controlling
the production of NO and cGMP remain unclear. Previous studies have shown
activation of NO/cGMP production in response to stimulation with
N-methyl-d-aspartate (NMDA) or nicotine, and the differential modulation
of cGMP production by GABAA and GABAC receptors
(GABAARs and GABACRs). This study used cGMP
immunocytochemistry and NO imaging to investigate how the inhibitory
GABAergic and glycinergic systems modulate the production of NO and cGMP.
Our data show that blocking glycine receptors (GLYR) with strychnine
(STRY) produced moderate increases in cGMP-like immunoreactivity (cGMP-LI)
in select types of amacrine and bipolar cells, and strong increases in
NO-induced fluorescence (NO-IF). TPMPA, a selective GABACR
antagonist, greatly reduced the increases in cGMP-LI stimulated by STRY,
but did not influence the increase in NO-IF stimulated by STRY.
Bicuculline (BIC), a GABAAR antagonist, however, enhanced the
increases in both the cGMP-LI and NO-IF stimulated by STRY. CNQX, a
selective antagonist for
α-Amino-3-hydroxy-5-methyl-4-isoxazoleproprionic acid
hydrobromide/kainic acid (AMPA/KA) receptors, eliminated both the
increases in cGMP-LI and NO-IF stimulated by STRY, while MK801, a
selective antagonist for NMDA receptors, slightly increased the cGMP-LI
and slightly decreased the NO-IF stimulated by STRY. Finally, double
labeling of NO-stimulated cGMP and either GLY or GABA indicated that cGMP
predominantly colocalized with GLY. Taken together, these findings support
the hypothesis that GLY and GABA interact in the regulation of the
NO/cGMP signaling pathway, where GLY primarily inhibits NO production
and GABA has a greater effect on cGMP production. Such interacting
inhibitory pathways could shape the course of signal transduction of the
NO/cGMP pathway under different physiological situations.